Indian equity benchmarks continued their upward momentum for the sixth consecutive session on Thursday, supported by sustained buying in pharma, banking, and energy stocks. The BSE Sensex closed 142.87 points higher at 82,000.71, while the NSE Nifty gained 33.20 points to settle at 25,083.75, crossing the psychological 25,050 mark for the first time this week.
Market Overview: Strength Amid Sectoral Rotation
Despite mixed global cues and selective profit booking, domestic indices remained resilient. The rally was led by large-cap pharma stocks and private banks, while midcap and smallcap indices showed signs of fatigue after a strong three-day run.
- Advancing stocks: 2,025
- Declining stocks: 1,886
- Unchanged: 145
The India VIX, which measures market volatility, declined over 3 percent to 11.37, indicating a stable trading environment and reduced investor anxiety.
Top Gainers: Pharma Stocks Outperform
Pharma stocks were the standout performers of the day. Cipla rose 3 percent, driven by strong quarterly earnings and positive sentiment around its product pipeline. Dr. Reddy’s Laboratories gained 2 percent, supported by robust export demand and margin expansion.
Other notable gainers included:
- ICICI Bank
- Bajaj Finserv
- SBI Life Insurance
These stocks benefited from institutional buying and favorable sectoral outlooks.
Sectoral Performance: Mixed Trends
Gaining Sectors:
- Pharma
- Oil & Gas
- Private Banks
- Realty
- Infrastructure
- Information Technology
Declining Sectors:
- FMCG
- Auto
- PSU Banks
- Consumer Durables
- Midcaps and Smallcaps
The divergence reflects a cautious approach by investors, with a preference for defensives and quality large-cap names.
Policy Developments: SEBI and GST in Focus
SEBI Chairman Tuhin Kanta Pandey, speaking at the FICCI Capital Market Conference, hinted at extending the tenure of equity derivatives. This move, if implemented, could reshape trading strategies and risk management practices.
Meanwhile, the Group of Ministers approved the Centre’s proposal for GST rate rationalisation, supporting a simplified two-slab structure. This reform is expected to boost consumption and improve compliance, particularly in the auto and consumer goods sectors.
Global Cues and Market Outlook
Global markets remained mixed amid geopolitical tensions and commodity price fluctuations. However, Indian equities showed resilience, supported by strong domestic fundamentals and policy clarity.
Key factors to watch in the coming sessions include:
- US Federal Reserve commentary on interest rates
- Crude oil price movements
- Domestic macroeconomic data including GDP and inflation
- Progress on GST reforms and SEBI’s regulatory updates
Conclusion: Momentum Intact, But Caution Advised
The sixth straight day of gains reflects investor confidence, but sectoral divergence and midcap weakness suggest a phase of consolidation. Pharma and private banks remain in favor, while auto and FMCG may face selective pressure until policy clarity improves.
With Nifty breaching 25,000 and Sensex holding above 82,000, the short-term trend remains positive. However, traders and investors are advised to stay cautious, manage risk, and rely on research-backed strategies—especially from SEBI-registered analysts who offer regulated, data-driven insights.
Top-notch SEBI registered research analyst
Best SEBI registered Intraday tips provider
Telegram | Facebook | Instagram
Call: +91 9624421555 / +91 9624461555